ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,522,655, issued on Jan. 13, was assigned to Paragon Therapeutics Inc. (Waltham, Mass.).

"IL-23 antibody compositions and methods of use" was invented by Byron Hua Kwan (Bothell, Wash.) and Hussam Hisham Shaheen (Auburn, N.H.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are interleukin 23 (IL-23) binding proteins (e.g., antibodies) and methods of use."

The patent was filed on July 23, 2025, under Application No. 19/278,342.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&...